
Truly INDIVIDUALIZED treatment
for EVERY round of therapy
Our vision is to TRANSFORM LIFE-THREATENING DISEASES INTO TREATABLE CONDITIONS by designing INDIVIDUALIZED therapeutics at EVERY stage of the disease.
The Aummune Therapy
The Need
Today's "personalized medicine" is based on molecular pathways and cancer cells are known to develop resistance to therapies that target a specific pathway.

The Therapy
The Aummune process is based on the company’s breakthrough therapy produced by a proprietary molecular computational process.

The Advantages
Aummune develops a tailored therapy that combats rapidly evolving diseases at every stage.
The Aummune Process
21-Day, De Novo, Personalized Therapy Development

Tumor Sample


Tissue Processing


Evomer™ Computing

Validation


Treatment


Day 0


Day 21
End-to-End Service
Our Team

Guy Neev
CEO

Irit Carmi-Levy, PhD
CSO

Dr. Yair Schindel
Chairman

Prof. Raanan Berger
CMO

Marius Nacht
Co-Founder

Dr. Ido Bachelet
CTO